Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-04-30T22:47:13.499Z Has data issue: false hasContentIssue false

160 - Yersinia

from Part XVIII - Specific organisms: bacteria

Published online by Cambridge University Press:  05 April 2015

Royce H. Johnson
Affiliation:
David Geffen School of Medicine
Arash Heidari
Affiliation:
David Geffen School of Medicine
David Schlossberg
Affiliation:
Temple University, Philadelphia
Get access

Summary

Introduction

The genus Yersinia consists of 17 species. Only three species are consistently pathogenic for humans. These are Yersinia pestis, the agent of plague, Yersinia enterocolitica, and Yersinia pseudotuberculosis, which are usually, but not entirely, gastrointestinal pathogens.

Yersinia pestis

An ongoing result of the unfortunate events of September 11, 2001 has been an increase in research on Yersinia, particularly, Y. pestis. This is an ancient organism and since its divergence from Y. pseudotuberculosis 1500 to 20 000 years ago has largely existed as a rodent pathogen with only occasional human transmission. Three well-described pandemics of plague have occurred. The last of these began in the nineteenth century. Alexandre Yersin first isolated Y. pestis in 1894. The twentieth century saw major outbreaks in Vietnam and India. The majority of cases currently are seen in sub-Saharan Africa, particularly Madagascar.

The majority of cases seen in the United States are from the southwestern states of New Mexico, Arizona, Colorado, Texas, and California. Climate change may well affect the bacteria, the vector, and the hosts, resulting in potential worldwide changes in the frequency and distribution of disease. In 2010 two human cases were reported in Oregon

There has been remarkable progress in the understanding of the pathogenesis of Yersinia infections, particularly those caused by Y. pestis. A partial list of these advances include the effects of Y. pestis on flea behavior, and its avoidance of both innate and adaptive (both humeral and cellular) immune response.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Butler, T. Plague into the 21st century. Clini Infect Dis. 2009;49:736–742.CrossRefGoogle ScholarPubMed
Lemaitre, N, Ricard, I, Pradel, E, et al. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. PLoS One. 2012;7(12):e52503.CrossRefGoogle ScholarPubMed
Li, B, Yang, R. Interaction between Yersinia pestis and the host immune system. Infect. Immun. 2008;76(5):1804–1811.CrossRefGoogle ScholarPubMed
Louie, A, VanScoy, B, Liu, W, et al. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2011;55(6):2623–2628.CrossRefGoogle Scholar
Mwengee, W, Butler, T, Mgema, S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42:614–621.CrossRefGoogle ScholarPubMed
Rosner, BM, Stark, K, Werber, D. Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001–2008. BMC Public Health. 2010;10:337. .CrossRefGoogle Scholar
Stenseth, NC, Atshabar, BB, Begon, M, et al. Plague: past, present, and future. PLoS Med. 2008;5(1):e3.CrossRefGoogle ScholarPubMed
Tsang, TM, Felek, S, Krukonis, ES. Ail binding to fibronectin facilitates Yersinia pestis binding to host cells and Yop delivery. Infect Immun. 2010;78(8):3358–3368.CrossRefGoogle ScholarPubMed
Urich, SK, Chalcraft, L, Schriefer, ME, et al. Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia. Antimicrob Agents Chemother. 2012;56(1):555–558.CrossRefGoogle ScholarPubMed
Wendte, JM, Ponnusamy, D, Reiber, D, et al. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Antimicrob Agents Chemother. 2011;55(8):3752–3757.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Yersinia
  • Edited by David Schlossberg, Temple University, Philadelphia
  • Book: Clinical Infectious Disease
  • Online publication: 05 April 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139855952.179
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Yersinia
  • Edited by David Schlossberg, Temple University, Philadelphia
  • Book: Clinical Infectious Disease
  • Online publication: 05 April 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139855952.179
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Yersinia
  • Edited by David Schlossberg, Temple University, Philadelphia
  • Book: Clinical Infectious Disease
  • Online publication: 05 April 2015
  • Chapter DOI: https://doi.org/10.1017/CBO9781139855952.179
Available formats
×